4 мин. чтения

Ozone Therapy in Oncology: Biological Claims, Evidence, and Safety Concerns

1. Introduction: A Reactive Gas Turned Into a «Therapy»

Ozone (O3) is a highly reactive form of oxygen and a well-known air pollutant and respiratory irritant. It is also used industrially as a disinfectant. On the basis of its oxidizing properties, ozone has been promoted as a medical treatment for many conditions, including cancer, typically through «ozone autohemotherapy» (withdrawing blood, mixing it with ozone gas, and reinfusing it), rectal or vaginal insufflation, or direct injection. There is no high-quality evidence that ozone therapy treats cancer, and it carries a risk of serious, occasionally fatal, complications. This article explains the claims, the evidence, and the hazards.


2. Claims and Proposed Mechanisms

Proponents argue that ozone, by generating reactive oxygen species and transient oxidative stress, can (1) directly kill tumor cells, (2) stimulate the immune system, (3) improve oxygen delivery to tissues, and (4) promote «detoxification.» Some of these ideas have a superficial resemblance to real biology — oxidative stress is a genuine mechanism in some therapies, and immune modulation is central to immunotherapy — but the leap from a laboratory oxidant to a safe and effective systemic cancer treatment is large and unsupported. The controlled, dose-targeted delivery that makes oxidative therapies useful in specific settings (such as photodynamic therapy) is absent in ozone «therapy,» and ozone’s reactivity means it reacts immediately at the site of contact rather than traveling to tumors.


3. The Evidence

The published clinical literature on ozone therapy in cancer consists largely of small, uncontrolled series, case reports, and studies with methodological problems. There are no large randomized controlled trials demonstrating that ozone therapy improves survival, tumor response, or quality of life in cancer patients. Systematic reviews of ozone therapy for various conditions have found low-quality evidence and have not established effectiveness. As a result, ozone is not recognized as a cancer treatment by any major oncology body. Claims of benefit should be regarded as unsubstantiated.


4. Documented Harms

  • Air/gas embolism. Injection or insufflation of gas can introduce gas into the bloodstream, causing embolism that may be fatal. This is a recognized, serious complication of ozone procedures.
  • Pulmonary toxicity. Inhaled ozone damages the respiratory tract and lungs; ozone generators are not approved for inhalation.
  • Infection and contamination. Non-sterile procedures and non-medical-grade equipment risk introducing pathogens, including through non-standard routes.
  • Hemolysis and other hematologic effects from exposing blood to a strong oxidant.
  • Delay of effective treatment — the most consequential indirect harm.

5. Regulatory Status and Warnings

Health regulators have repeatedly warned against the medical use of ozone outside controlled, approved applications. The US Food and Drug Administration has stated that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy and has warned that ozone generators marketed for medical use are not approved. Ozone therapy for cancer is therefore both unproven and, in many jurisdictions, unauthorized.


6. Early Research and Speculative Directions

  • Laboratory studies of ozone’s effects on cells and immune signaling exist, but they do not establish a safe or effective therapeutic window for treating cancer in patients.
  • Any future use would require rigorous controlled trials with defined dosing, delivery, and safety monitoring — none of which currently support clinical use.

7. Unresolved Questions and Speculative Directions

  • Whether any controlled, targeted oxidative therapy based on ozone could ever be safe and effective in oncology is speculative and currently unsupported. [Marked for verification.]

8. Conclusion

Ozone therapy has no established role in cancer treatment. Its rationale relies on generic oxidative stress without controlled, targeted delivery, and the clinical evidence consists of low-quality, uncontrolled reports. It carries documented risks, including potentially fatal gas embolism and pulmonary toxicity, and regulators have warned against its medical use. Ozone therapy should not be used for cancer, and it should never replace or delay evidence-based treatment.


Sources and Key Research Centers

  • National Cancer Institute — PDQ summaries on complementary and alternative medicine.
  • US Food and Drug Administration — warnings on ozone generators marketed for medical use and on fraudulent cancer cures.
  • Cochrane Library — reviews of ozone therapy finding low-quality evidence.
  • Case reports of gas embolism from ozone procedures — reported in the medical literature. [Citation details to be verified.]
  • FDA statement on ozone generators — «FDA warns against using ozone generators for medical purposes» (2019). [Verify details.]

Note: citation identifiers are provided where available; readers should confirm bibliographic details against the publisher’s record. This article is an editorial scientific overview and is not a medical recommendation.